Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

  • This share is currently suspended. It was suspended at a price of 0.742
  • There is currently no data for BGLF

Directorate Change

8 Jan 2019 16:00

RNS Number : 5450M
Blackstone / GSO Loan Financing Ltd
08 January 2019
 

8 January 2019

 

Blackstone / GSO Loan Financing Limited (the "Company")

 

Appointment of a New Non-Executive Director

 

The Company is pleased to announce that Mr Mark Moffat has been appointed as a non-executive director with effect from 8 January 2019.

 

Mark has been involved in the structuring, managing and investing in CLOs for over 20 years. Mark resigned from GSO Capital Partners LP ("GSO"), part of the credit businesses of The Blackstone Group L.P. and an affiliate of the Company's Portfolio Adviser, in early 2015 to pursue other interests.

 

Whilst at GSO, Mark was a Senior Managing Director, Co-Head of the European activities of GSO's Customized Credit Strategies division, and the portfolio manager responsible for funds investing in structured credit, including Carador Income Fund PLC (LSE: CIFU LN). Mark joined GSO in January 2012 following GSO's acquisition of Harbourmaster Capital Management Limited, where he was co-head. Prior to joining Harbourmaster in 2007, Mark was a Senior Managing Director at Bear Stearns, Head of European Debt and Equity Capital Markets and Head of the European CDO business. Whilst at Bear Stearns, Mark led the successful development of the European CDO business over a seven-year period, during which the business was a leader in the securitisation of leveraged loans, asset backed securities, and credit default swaps in Europe. He also sat on the leveraged loan and asset backed securities warehouse committees at Bear Stearns. Prior to Bear Stearns, Mark held similar roles at ABN AMRO where he was global head of CLOs and at Greenwich NatWest, where he was a Director in the Principal Finance Team.

 

The Board does not consider Mark to be an independent director due to his recent employment with GSO. However, the Board believes that his knowledge and experience will be a valuable addition to the Board.

 

There are no matters in respect of Mr Moffat requiring disclosure under paragraphs 9.6.13 (1) to (6) of the Listing Rules.

 

Contacts:

 

BNP Paribas

Melissa Le Cheminant/Siobhan Lavery 01534 813873 / 709181

 

Fidante Capital

John Armstrong-Denby/Nick Donovan 020 7832 0900

 

N+1 Singer Advisory LLP

David Floyd/James Maxwell 07785 938 065 / 02074 963056

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUPAGUPBGAR
Date   Source Headline
16th Jan 20258:00 amRNSCancellation - Blackstone Loan Financing Limited
15th Jan 202512:15 pmRNSResult of Extraordinary General Meeting
8th Jan 20254:39 pmRNSFurther re Sale of Assets and Third Redemption
2nd Jan 202511:19 amRNSTotal Voting Rights
2nd Jan 20259:43 amRNSFurther Re Proposed Sale of Assets
19th Dec 202412:37 pmRNSRESULTS OF EXTRAORDINARY GENERAL MEETING
4th Dec 20244:35 pmRNSCircular and Notice of General Meetings
2nd Dec 20247:01 amRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSCOMPULSORY PARTIAL REDEMPTION OF SHARES AND TVR
26th Nov 202412:21 pmRNSDividend Declaration
21st Nov 20246:31 pmRNSProposed Sale of Assets
21st Nov 20247:00 amRNSNet Asset Value and Publication of Monthly Report
21st Nov 20247:00 amRNSCompulsory Partial Redemption of Shares
18th Nov 20241:47 pmRNSQ3 2024 Report
13th Nov 20243:26 pmRNSHolding(s) in Company
8th Nov 20247:00 amRNSRedemption Update
30th Oct 202410:45 amRNSHolding(s) in Company
21st Oct 20247:00 amRNSDividend Declaration
21st Oct 20247:00 amRNSNet Asset Value and Publication of Monthly Report
20th Sep 20247:00 amRNSNet Asset Value and Publication of Monthly Report
20th Sep 20247:00 amRNSHalf-year Report
27th Aug 20243:54 pmRNSDividend Currency Election
22nd Aug 20247:00 amRNSNet Asset Value and Publication of Monthly Report
8th Aug 20242:46 pmRNSQ2 2024 REPORT
31st Jul 20241:02 pmRNSResult of AGM
19th Jul 202410:36 amRNSDividend Declaration
19th Jul 202410:36 amRNSNet Asset Value and Publication of Monthly Report
16th Jul 20244:44 pmRNSNotice of Annual General Meeting
12th Jul 202410:33 amRNSHolding(s) in Company
1st Jul 20243:46 pmRNSTotal Voting Rights
21st Jun 20244:15 pmRNSNet Asset Value and Publication of Monthly Report
13th Jun 20249:19 amRNSHolding(s) in Company
11th Jun 20243:37 pmRNSDirector/PDMR Shareholding
11th Jun 20247:00 amRNSCompulsory Partial Redemption of Shares and TVR
24th May 20243:45 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSNet Asset Value and Publication of Monthly Report
23rd May 20247:00 amRNSCompulsory Partial Redemption of Shares
21st May 20244:51 pmRNSDividend Currency Election
15th May 20242:46 pmRNSQ1 2024 Report
29th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value and Publication of Monthly Report
22nd Apr 20247:00 amRNSDividend Declaration
19th Apr 202412:31 pmRNSDirector Declaration
22nd Mar 20247:00 amRNSNet Asset Value and Publication of Monthly Report
23rd Feb 20244:44 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20247:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd Jan 20247:00 amRNSDividend Declaration
22nd Jan 20245:05 pmRNSNet Asset Value and Publication of Monthly Report
22nd Dec 20237:00 amRNSCancellation of Treasury Shares
21st Dec 20234:13 pmRNSIssuance of Deferred Share

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.